E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers I > Headlines for Immune Response Corp. > News item
Published on 12/19/2005 in the Prospect News Biotech Daily.

Immune Response stock quoted on OTC Bulletin Board

By Angela McDaniels

Seattle, Dec. 19 - The Immune Response Corp. said its stock has been listed on the OTC Bulletin Board and began trading under the ticker symbol "IMNR" on Monday.

The stock closed at $0.13 on Monday.

Immune Response is a biopharmaceutical company based in Carlsbad, Calif., that develops immune-based therapies for HIV and multiple sclerosis.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.